Tumor necrosis factor-alpha inhibitor associated psoriasiform alopecia (drug-induced psoriasiform alopecia)

2012 ◽  
pp. 102-107
Keyword(s):  
Tumor Necrosis Factor ◽  
Tumor Necrosis Factor Alpha ◽  
Tumor Necrosis ◽  
Drug Induced ◽  
Necrosis Factor Alpha ◽  
Factor Alpha ◽  
Necrosis Factor

Salivary interleukin-6 and tumor necrosis factor alpha in patients with drug-induced xerostomia

Oral Diseases ◽  
2006 ◽  
Vol 12 (5) ◽  
pp. 509-511 ◽  
Author(s):  
V Vučićević Bora ◽  
V Brailo ◽  
J Lukač ◽  
D Kordić ◽  
P Picek ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Tumor Necrosis Factor Alpha ◽  
Interleukin 6 ◽  
Tumor Necrosis ◽  
Drug Induced ◽  
Necrosis Factor Alpha ◽  
Factor Alpha ◽  
Necrosis Factor

scholarly journals Lichen planopilaris induced by infliximab: A case report

2020 ◽  
Vol 8 ◽  
pp. 2050313X2090196 ◽  
Author(s):  
Meghan L McPhie ◽  
Ami Wang ◽  
Sonja Molin ◽  
Thomas Herzinger
Keyword(s):  
Drug Reaction ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis Factor Alpha ◽  
Tumor Necrosis ◽  
Hair Follicles ◽  
Drug Induced ◽  
Necrosis Factor Alpha ◽  
Lichen Planopilaris ◽  
Factor Alpha ◽  
Necrosis Factor

Infliximab is a tumor necrosis factor-alpha inhibitor used to treat a range of inflammatory diseases. Most reports of cutaneous eruptions from tumor necrosis factor-alpha inhibitors have described the paradoxical development of psoriasis or psoriasiform drug reaction. In our report, we present a 31-year-old female with inflammatory bowel disease who developed an unusual lichenoid drug reaction to infliximab involving the hair follicles, resulting in progressive global alopecia. Clinical features and histopathological findings were consistent with drug-induced lichen planopilaris with eosinophils and lichenoid dermatitis.

Sign in / Sign up

Export Citation Format

Share Document